Identification of factors associated with the efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder.

Aim: Atomoxetine (ATX) is a non-central stimulant and a standard treatment for adult attention-deficit/hyperactivity disorder (ADHD). The long-term efficacy of Atomoxetine is about 40% at 6 months. The variability in efficacy between individuals is thought to be related to patient-specific factors, but no detailed research has been conducted.

Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy.

Background: We conducted a historical cohort study of patients with schizophrenia to identify more robust risk factors at discharge that contribute to readmission within a year.

Methods And Findings: The subjects underwent brief psychoeducation during hospitalization. Multivariate analysis was conducted using factors selected in the univariate analysis.

Asphyxia risk factors in adult psychiatric wards.

Purpose: To identify factors for choking in psychiatric wards that can be easily screened.

Design And Methods: Data were collected from patients admitted to the acute phase psychiatric wards who were assessed for swallowing function by dentists. We defined 47 and 102 patients of choking in the high- and low-risk groups, respectively.